Cognitive Disorders Clinical Trial
Official title:
Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked Potentials
The aim of the MAPEG 2 study is to explore gustatory function and to follow its evolution in the 5 following groups of participants: - Healthy subjects - Participants with isolated cognitive complaint - Participants with minor neurocognitive disorder - Participants with mild Alzheimer-type major neurocognitive disorders - Participants with moderate Alzheimer-type major neurocognitive disorders For this purpose, we want to compare the results of the following tests: - Subjective taste tests (tasting solutions, answering food preference questionnaires), - Gustatory evoked potential (GEP) parameters, recorded by electrodes placed on the scalp, - And nutritional parameters (hormones of food intake by blood test, measurement of the global body composition). Identifying and following the evolution of early taste disorders in case of cognitive disorders could improve the diagnosis of Alzheimer's disease in two ways: - To allow an early diagnosis of Alzheimer's disease, and thus improve its management, - To define groups of subjects at risk of developing Alzheimer's disease in later years.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02554253 -
The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction
|
Phase 2 | |
| Recruiting |
NCT02777060 -
Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures
|
N/A | |
| Completed |
NCT02342041 -
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT01659593 -
Evaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis Patients
|
N/A | |
| Completed |
NCT01561820 -
Mild Cognitive Impairment, Buddy Supported Exercise/ My Buddy Study
|
N/A | |
| Completed |
NCT00743405 -
Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT05373394 -
Evaluation of Cognitive and Motor Neurological Disorders in the Short and Long Term After Surgery for the Removal of a Diffuse Low-grade Glioma of the Supplementary Motor Area
|
||
| Completed |
NCT04860414 -
Prospective Monocentric Study of Taste in Patients With Minor or Major Cognitive Disorders Such as Alzheimer's, Through the Analysis of Gustatory Evoked Potentials.
|
N/A | |
| Completed |
NCT02324153 -
Ramelteon in the Prevention of Post-operative Delirium
|
Phase 2 | |
| Completed |
NCT00458094 -
Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses
|
N/A | |
| Completed |
NCT05486195 -
A Single Ascending Oral Dose Study of SDI-118 in Healthy Male Subjects Including an Assessment of Receptor Occupancy and Food Effect
|
Phase 1 | |
| Not yet recruiting |
NCT03866018 -
Contribution of Physical Activity to Self-esteem and Motivation in Older Adults With Minor to Major Cognitive Disorders Such as Alzheimer's Disease or Related Disorders
|
N/A | |
| Recruiting |
NCT02876536 -
Effect of Transcutaneous Electrical Nerve Stimulation on Cognition in Multiple Sclerosis Patients
|
N/A | |
| Completed |
NCT02321475 -
EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders
|
||
| Completed |
NCT01881646 -
Postoperative Neuroinflammation and Cognitive Dysfunction After Abdominal Surgery
|
Phase 4 | |
| Completed |
NCT01983384 -
Anesthetic Depth and Postoperative Delirium Trial - 2
|
N/A | |
| Completed |
NCT02575482 -
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-D4010 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT00937846 -
Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study
|
Phase 1 | |
| Completed |
NCT01772095 -
ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE
|
N/A | |
| Completed |
NCT06078332 -
Remote Cognitive Multidomain Assessment in People With Cognitive Disorders
|